Three Critiques of the DanGer-Shock Trial
Sensible Medicine
JUNE 3, 2024
For the study-of-the-week, we will publish a criticism of the DanGer-Shock trial. He and colleagues sent me sharp critiques of the DanGer-Shock trial, which compared the micro-axial flow pump (brand name Impella) vs standard care in patients who had cardiogenic shock due to myocardial infarction. A brief intro to DanGer-Shock.
Let's personalize your content